Sony executive Sanford panitch believes audiences will have a clearer picture of how Sony/Marvel properties like Venom Tie into the MCU after SpiderMan no way home
One of the worst kept secrets in Hollywood is that “No Way Home” will be diving headfirst into the multiverse, and incorporating characters from Sony’s earlier “Spider-Man” movies that starred Tobey Maguire and Andrew Garfield. Alfred Molina, for example, told Variety in April that he will be digitally de-aged in “No Way Home” to look like he did as the villain Doc Ock at the end of 2004’s “Spider-Man 2.”
There will be more revealed after the release of Spiderman No Way Home. Sony is also opposing to not give their characters be part of MCU. “Kraven” is the newest initiative in Sony’s repeated attempt to cash in on the slew of Marvel characters that came with the Spider-Man film rights. Along with Tom Hardy’s “Venom” and its impending sequel “Venom: Let There Be Carnage,” which stars Woody Harrelson as the title villain, Sony has Jared Leto in the role of the vampiric “Morbius,” which will be released on Jan. 21.
To yet, none of these films expressly include SpiderMan — or, at least, the Tom Holland version of the character, who is still part of Sony’s groundbreaking deal with Disney’s Marvel Studios to share the famous web-slinger. “Spider-Man: No Way Home,” the most recent and (at least on paper) last picture in the relationship, is due to hit theatres this December. Panitch, on the other hand, makes a point of distinguishing Spidey from the company’s other superhero series.
He explains, “We don’t really conceive of our 900 characters as the Spidey-verse.” “We have a Marvel universe,” says the narrator. Wait till you see the next ‘Venom,’ the number of characters we have. Spider-Man isn’t missed.”
He takes a breather. “Won’t it be fantastic if they do meet?”
That’s where the problem begins. The tangled web between Sony’s Marvel-verse and Disney’s Marvel Cinematic Universe is especially puzzling in the realm of huge comic-book worlds. Because Holland’s Peter Parker is a member of the MCU, any appearance he makes in subsequent Marvel films by Sony would appear to retroactively include characters like Tom Hardy’s Venom and Taylor-Kraven. Johnson’s. On the Holland films, Marvel Studios is merely a co-producer with Sony. To add to the confusion, Michael Keaton, who played the Spider-Man villain Vulture in the Sony/Marvel Studios co-production “Spider-Man: Homecoming,” was teased in the first teaser for “Morbius.”
Panitch recognizes that the inherent tension in this tangled web of intellectual property has caused fans to be perplexed and frustrated. While he stays tight-lipped about specifics, Panitch is open about his expectation that the tension will be addressed soon…somehow — and that greenlighting “Kraven,” a character who has also fought Venom in the comics, adds another piece to the jigsaw. “There is a strategy,” he explains. “I believe it’s becoming clearer for folks where we’re going now, and I believe much more will be revealed when ‘No Way Home’ is released.”
One of Hollywood’s best-kept secrets is that “No Way Home” will plunge headfirst into the multiverse, including characters from Tobey Maguire and Andrew Garfield’s previous “Spider-Man” films. In April, Alfred Molina informed Variety that in “No Way Home,” he will be digitally de-aged to appear as he did as the villain Doc Ock at the end of 2004’s “Spider-Man 2.”
The suggestion is that whatever occurs in “No Way Home” will allow Holland to continue appearing in Sony’s Marvel films while still being a member of the MCU in some way. However, “No Way Home” is the final picture in Marvel and Sony’s existing contract to share the character, except another cameo by Holland’s Spidey in an as-yet-unannounced Marvel Studios picture. When questioned about the future of Spider-Man and Marvel Studios, Panitch strikes an upbeat, albeit hazy, tone, evoking Marvel Studios President Kevin Feige.
“The best part is that we have this fantastic relationship with Kevin,” he explains. “There’s a fantastic sandbox to play in there. We want those MCU films to be massive because it’s good for us and our Marvel characters, and I believe they want the same thing. However, we have a fantastic relationship. There are a lot of chances, I believe, that will arise.” One of those changes appears to be developing a film on the Sinister Six, a group of Spider-Man villains that includes Doc Ock and Kraven. Sony attempted it once previously, as a spin-off from “The Amazing Spider-Man 2” in 2014.
FIND MAXBLIZZ ON TWITTER